Astorg's subsidiary Oxoid Remel Microbiology will carve out its microbiology diagnostic division from fellow portfolio company Solabia as part of internal M&A strategy. The move creates a leading global platform for clinical diagnostics, food safety, and pharmaceutical testing while allowing Solabia to focus on biotech for cosmetics and life sciences. Meanwhile, Platinum Equity has signed a definitive agreement to acquire a majority stake in Trime, an Italian manufacturer of mobile lighting towers, generators, and security towers headquartered in Cassinetta di Lugagnano near Milan.
Founder Andrea Fontanella and CEO Paolo Tacconi will invest alongside Platinum in this resilient cash-generative business serving infrastructure, construction, mining, and events markets across more than 30 countries. The deal includes investments in production capacity, US sales coverage, warehousing, spare-parts availability, and customer support. These transactions highlight Astorg's portfolio restructuring and Platinum Equity's expansion in the lighting tower sector.
Source: PE Hub · Summarized by HeadlinesBriefing